Abstract
Generic drugs may differ from brand-name drugs in nature and quantity of excipients. Hypersensitivity to generic drugs is a subject of growing importance given their key role in healthcare spending policies, however, a review of published data highlighted that relevant data is sparse. No scientific rationale has emerged for labelling patients allergic to all generic drugs, and hypersensitivity to generic drugs may rather be explored on a case-by-case basis. In the case of hypersensitivity without any change in medication, it is advisable to check for a switch from a brand-name to a generic drug, and if hypersensitivity to a generic drug is suspected, its composition must be checked.
Article PDF
Avoid common mistakes on your manuscript.
References
Trying times for generic medicines in the USA. Lancet Lond 2013; 381: 1072.
Yang YT, Nagai S, Chen BK, et al. Generic oncology drugs: are they all safe? Lancet Oncol 2016; 17: e493–501.
Ministère des affaires sociales, de la santé et des droits des femmes. Plan national d’action de promotions des médicaments génériques [Internet]. 2015. Disponible sur: https://solidarites-sante.gouv.fr/IMG/pdf/plan_national_medicaments_generiques_24mars2015.pdf [cité 24/12/2021].
Hadwiger ME, Sommers CD, Mans DJ, Patel V, Boyne MT. Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays. Antimicrob Agents Chemother 2012; 56: 2824–30.
Wood AJJ. Playing “kick the FDA” risk-free to players but hazardous to public health. N Engl J Med 2008; 358: 1774–5.
Badiu I, Guida G, Heffler E, Rolla G. Multiple drug allergy due to hypersensitivity to polyethylene glycols of various molecular weights. J Investig Allergol Clin Immunol 2015; 25: 368–9.
Bosak M, Słowik A, Dziedzic T. Brand-to-generic oxcarbazepine switch — A prospective observational study. Epilepsy Res 2019;151:75–7.
Gernez Y, Barlesi F, Astoul P, Magnan A. Hypersensitivity to carboplatin. An effect of generic drugs? Rev Mal Respir 2006; 23: 269–72.
Tampellini M, Benedetto S, Rubatto E, et al. Bioequivalence of branded and generic oxaliplatin: from preclinical assessment to clinical incidence of hypersensitivity reactions. Anticancer Res 2016;36:5163–70.
Elalami I, Ichou M. Generic docetaxel chemotherapy induced skin toxicities in breast cancer patient. Pan Afr Med J 2016; 24: 164.
Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Soyama H, Kato K, et al. Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy? Cancer Chemother Pharmacol 2017; 80: 65–9.
Garrido-Siles M, Arenas-Villafranca JJ, Pérez-Ruiz E, et al. New cutaneous toxicities with generic docetaxel: are the excipients guilty? Support Care Cancer 2015; 23(7): 1917–23.
Ratanajarusiri T, Sriuranpong V, Sitthideatphaiboon P, et al. A difference in the incidences of hypersensitivity reactions to original and generic taxanes. Chemotherapy 2017; 62: 134–9.
Sabroe TP, Sabers A. Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product. Acta Neurol Scand 2008;117:428–31.
Shinoda R, Shinoda Y, Ohashi K, et al. Single-centre retrospective observational study comparing trough blood concentration and safety of teicoplanin formulations. J Infect Chemother 2019;25: 563–6.
Gallardo W, de Las Casas MI, Mercado M. A cautionary note on generic depot octreotide. Pituitary 2015; 18: 581–2.
Chandeclerc M-L, Tréchot P, Martin S, Weber-Muller F, Schmutz J-L, Barbaud A. Cutaneous adverse drug reaction induced by a generic substitute of Zyloric with a residual sensitization to allopurinol. Allergy 2006; 61:1492–3.
Dueñas-Laita A, Pineda F, Armentia A. Hypersensitivity to generic drugs with soybean oil. N Engl J Med 2009;361: 1317–8.
Morishima R, Bokuda K. Hydroxypropyl cellulose-induced fixed drug eruption as an adverse effect of generic drugs. Contact Dermatitis 2021;85:90–1.
Mumoli N, Cei M, Luschi R, Carmignani G, Camaiti A. Allergic reaction to Croscarmellose sodium used as excipient of a generic drug. QJM Mon J Assoc Physicians 2011; 104:709–10.
Meissner M, Kaufmann R. Annular leukocytoclastic vasculitis after the administration of an amlodipine generic. J Eur Acad Dermatol Venereol 2009; 23: 238–9.
Brennan TA, Lee TH. Allergic to generics. Ann Intern Med 2004;141:126–30.
Barbaud A. Place of excipients in systemic drug allergy. Immunol Allergy Clin North Am 2014; 34:671–9.
Goossens RA. Allergic contact dermatitis from the vehicle components of topical pharmaceutical products. Immunol Allergy Clin North Am 2014;34:663–70.
Bruusgaard-Mouritsen MA, Johansen JD, Garvey LH. Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clin Exp Allergy J Br Soc Allergy Clin Immunol 2021;51:463–70.
Caballero ML, Quirce S. Immediate hypersensitivity reactions caused by drug excipients: a literature review. J Investig Allergol Clin Immunol 2020; 30: 86–100.
Caballero ML, Quirce S. Delayed hypersensitivity reactions caused by drug excipients: a literature review. J Investig Allergol Clin Immunol 2020;30:400–8.
Acknowledgements
the authors are grateful to Nikki Sabourin-Gibbs, CHU Rouen, for her help in editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
none
About this article
Cite this article
Tetart, F., Gonde, H. & Hervouët, C. Do generic drugs cause hypersensitivity?. Eur J Dermatol 32, 571–576 (2022). https://doi.org/10.1684/ejd.2022.4291
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2022.4291